Several studies have shown that insulin-like growth factor-binding proteins (IGF-BPs) modify IGF activity. To investigate their role in regulating growth, the number and size of IGF-BPs in porcine serum and the role of nutritional and endocrine factors in controlling their relative abundance were determined. IGF-BPs were analyzed by ligand blotting; sera were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, then the separated proteins were transferred to nitrocellulose filters and probed with [125I]IGF-I or -II. The band intensities of various forms of IGF-BPs were quantified by scanning densitometry. Fetal and postnatal sera contained six IGF-BPs of 220,000, 43,000, 39,000, 34,000, 29,000, and 24,000 mol wt (Mr). The band intensity of all forms of IGF-BPs increased with advancing gestational age. Specifically, the intensities of the 43,000, 39,000, 34,000, 29,000, and 24,000 Mr IGF-BP bands were 2.8-, 2.7-, 4.3-, 4.4-, and 3.1-fold higher, respectively, in fetal plasma at 110 than at 45 days gestation. In fetal plasma the 34,000 and 29,000 Mr forms predominated, whereas postnatally, the 43,000 and 39,000 Mr IGF-BPs predominated. Fasting of newborn pigs for 24 h reduced the intensity of the 43,000, 39,000, 34,000, and 24,000 Mr forms to 11.5%, 7.2%, 69.8%, and 5.2% of control levels, respectively. However, the 29,000 Mr IGF-BP was 1.8-fold higher in fasted pig serum than in that of fed controls. The band intensities of the 34,000 and 29,000 Mr forms were increased in postnatal animals after hypophysectomy. In contrast, fetal decapitation resulted in a preferential decrease in only the 34,000 Mr form, which was reduced by 30% compared to that in age-matched controls. These studies indicate that porcine serum contains six IGF-BPs that can be detected by ligand blotting. The level of each of these proteins increases with advancing gestational age, although the increases are not uniform, suggesting that the proteins may be regulated differentially. In the postnatal animal both endocrine and nutritional factors modulate the levels of IGF-BPs by distinct controlling mechanisms.

Insulin-like growth factor binding proteins (IGFBPs) are secreted by several cell types and can modify IGF actions. Mandin-Darby Bovine Kidney (MDBK) cells have been shown to secrete a 34,000 Da form of IGF binding protein whose N-terminal sequence is similar to a form of IGFBP purified from rat BRL-3A cells that has recently been named IGFBP-2. These studies report the complete amino acid sequence of bovine IGFBP-2 and compare its functional properties with human IGFBP-1. The protein is 81% identical to rat IGFBP-2. When compared with both rat IGFBP-2 and human IGFBP-1, the positions of all 18 cysteine residues are conserved. Similarly an RGD sequence is present near the carboxyl terminus in both proteins. IGFBP-2 has a higher affinity for IGF-II than for IGF-I and its affinity for both forms of IGF is greater than for human IGFBP-1. Like IGFBP-1 the protein can enhance the DNA synthesis response of porcine aortic smooth muscle cells to IGF-I; however, IGFBP-2 was much less potent. The maximum potentiation of the IGF-mediated mitogenic response that could be achieved was approximately 42% that of IGFBP-1. This potentiation is dependent upon a factor contained in platelet poor plasma and if this factor is omitted from the incubation medium, IGFBP-2 inhibits DNA synthesis. The purification of IGFBP-2 will allow more detailed comparisons to be made between it and other forms of IGFBPs in physiologic test systems.